These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 31293509)

  • 1. A Canine Model of Hemorrhagic Transformation Using Recombinant Tissue Plasminogen Activator Administration After Acute Ischemic Stroke.
    Jiang RH; Zu QQ; Xu XQ; Wang B; Ding Y; Wang J; Liu S; Shi HB
    Front Neurol; 2019; 10():673. PubMed ID: 31293509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between reperfusion and hemorrhagic transformation in acute ischemic stroke.
    Horsch AD; Dankbaar JW; van der Graaf Y; Niesten JM; van Seeters T; van der Schaaf IC; Kappelle LJ; Velthuis BK;
    Neuroradiology; 2015 Dec; 57(12):1219-25. PubMed ID: 26337766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GSK-3β inhibitor TWS119 attenuates rtPA-induced hemorrhagic transformation and activates the Wnt/β-catenin signaling pathway after acute ischemic stroke in rats.
    Wang W; Li M; Wang Y; Li Q; Deng G; Wan J; Yang Q; Chen Q; Wang J
    Mol Neurobiol; 2016 Dec; 53(10):7028-7036. PubMed ID: 26671619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canonical Wnt Pathway Maintains Blood-Brain Barrier Integrity upon Ischemic Stroke and Its Activation Ameliorates Tissue Plasminogen Activator Therapy.
    Jean LeBlanc N; Menet R; Picard K; Parent G; Tremblay MÈ; ElAli A
    Mol Neurobiol; 2019 Sep; 56(9):6521-6538. PubMed ID: 30852795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous infusion of mesenchymal stem cells inhibits intracranial hemorrhage after recombinant tissue plasminogen activator therapy for transient middle cerebral artery occlusion in rats.
    Nakazaki M; Sasaki M; Kataoka-Sasaki Y; Oka S; Namioka T; Namioka A; Onodera R; Suzuki J; Sasaki Y; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
    J Neurosurg; 2017 Oct; 127(4):917-926. PubMed ID: 28059661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IM-12 activates the Wnt-β-catenin signaling pathway and attenuates rtPA-induced hemorrhagic transformation in rats after acute ischemic stroke.
    Wang T; Duan YM; Fu Q; Liu T; Yu JC; Sui ZY; Huang L; Wen GQ
    Biochem Cell Biol; 2019 Dec; 97(6):702-708. PubMed ID: 31770017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of connexin43 in hemorrhagic transformation after thrombolysis in vivo and in vitro.
    Yang X; Chu H; Tang Y; Dong Q
    Neuroscience; 2016 Aug; 329():54-65. PubMed ID: 27138645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baicalin Attenuates Blood-Brain Barrier Disruption and Hemorrhagic Transformation and Improves Neurological Outcome in Ischemic Stroke Rats with Delayed t-PA Treatment: Involvement of ONOO
    Chen H; Guan B; Chen X; Chen X; Li C; Qiu J; Yang D; Liu KJ; Qi S; Shen J
    Transl Stroke Res; 2018 Oct; 9(5):515-529. PubMed ID: 29275501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLP-1R Agonist Exendin-4 Protects Against Hemorrhagic Transformation Induced by rtPA After Ischemic Stroke via the Wnt/β-Catenin Signaling Pathway.
    Liu C; Sun S; Xie J; Li H; Li T; Wu Q; Zhang Y; Bai X; Wang J; Wang X; Li Z; Wang W
    Mol Neurobiol; 2022 Jun; 59(6):3649-3664. PubMed ID: 35359227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of NLRP3 attenuates hemorrhagic transformation after delayed rtPA treatment in thromboembolic stroke rats: Involvement of neutrophil recruitment.
    Guo Z; Yu S; Chen X; Zheng P; Hu T; Duan Z; Liu X; Liu Q; Ye R; Zhu W; Liu X
    Brain Res Bull; 2018 Mar; 137():229-240. PubMed ID: 29258866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion.
    Pfefferkorn T; Rosenberg GA
    Stroke; 2003 Aug; 34(8):2025-30. PubMed ID: 12855824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remote ischemic conditioning attenuates blood-brain barrier disruption after recombinant tissue plasminogen activator treatment via reducing PDGF-CC.
    He Q; Ma Y; Fang C; Deng Z; Wang F; Qu Y; Yin M; Zhao R; Zhang D; Guo F; Yang Y; Chang J; Guo ZN
    Pharmacol Res; 2023 Jan; 187():106641. PubMed ID: 36587812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemorrhagic transformation is related to the duration of occlusion and treatment with tissue plasminogen activator in a nonembolic stroke model.
    Fagan SC; Nagaraja TN; Fenstermacher JD; Zheng J; Johnson M; Knight RA
    Neurol Res; 2003 Jun; 25(4):377-82. PubMed ID: 12870264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold Case of Thrombolysis: Cold Recombinant Tissue Plasminogen Activator Confers Enhanced Neuroprotection in Experimental Stroke.
    Huang Y; Gu S; Han Z; Yang Z; Zhong L; Li L; Wang R; Yan F; Luo Y; Borlongan C; Lu J
    J Am Heart Assoc; 2023 Sep; 12(17):e029817. PubMed ID: 37655472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid breakdown of microvascular barriers and subsequent hemorrhagic transformation after delayed recombinant tissue plasminogen activator treatment in a rat embolic stroke model.
    Dijkhuizen RM; Asahi M; Wu O; Rosen BR; Lo EH
    Stroke; 2002 Aug; 33(8):2100-4. PubMed ID: 12154270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
    Cai Y; Liu X; Chen W; Wang Z; Xu G; Zeng Y; Ma Y
    Exp Neurol; 2015 Apr; 266():120-6. PubMed ID: 25708985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Edaravone, a free radical scavenger, inhibits MMP-9-related brain hemorrhage in rats treated with tissue plasminogen activator.
    Yagi K; Kitazato KT; Uno M; Tada Y; Kinouchi T; Shimada K; Nagahiro S
    Stroke; 2009 Feb; 40(2):626-31. PubMed ID: 19095969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angong Niuhuang Wan reduces hemorrhagic transformation and mortality in ischemic stroke rats with delayed thrombolysis: involvement of peroxynitrite-mediated MMP-9 activation.
    Chen H; Luo Y; Tsoi B; Gu B; Qi S; Shen J
    Chin Med; 2022 Apr; 17(1):51. PubMed ID: 35477576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH.
    Niego B; Broughton BRS; Ho H; Sobey CG; Medcalf RL
    Fluids Barriers CNS; 2017 Nov; 14(1):33. PubMed ID: 29157263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New progress in the approaches for blood-brain barrier protection in acute ischemic stroke.
    Li Y; Zhong W; Jiang Z; Tang X
    Brain Res Bull; 2019 Jan; 144():46-57. PubMed ID: 30448453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.